The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients undergoing radical cystectomy (RC) for urothelial carcinoma but ineligible for neoadjuvant cisplatin-based chemotherapy.
 
Bradley C. Leibovich
No Relationships to Disclose
 
Tanner Miest
No Relationships to Disclose
 
Paul R Young
No Relationships to Disclose
 
Mark L. Gonzalgo
Stock and Other Ownership Interests - Gauss Surgical
Research Funding - NantWorks
Travel, Accommodations, Expenses - Gauss Surgical
 
Stephen A. Boorjian
Consulting or Advisory Role - Ferring; Sanofi
 
Matthew K. Tollefson
No Relationships to Disclose
 
R. Jeffrey Karnes
No Relationships to Disclose
 
Igor Frank
Patents, Royalties, Other Intellectual Property - Bard Medical
 
Timothy D. Lyon
No Relationships to Disclose
 
Tessa Kroeninger
No Relationships to Disclose
 
Shruthi Naik
Leadership - Vyriad
Stock and Other Ownership Interests - Vyriad
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent licensed from Mayo Clinic and being developed commercially by Vyriad
Travel, Accommodations, Expenses - Vyriad
 
Monica Reckner
Consulting or Advisory Role - Vyriad
 
Rosa M Diaz
Employment - Vyriad
Travel, Accommodations, Expenses - Vyriad
 
Stephen Kaesshaefer
No Relationships to Disclose
 
Ena Whitelaw
No Relationships to Disclose
 
Bethany A Brunton
No Relationships to Disclose
 
Alysha Newsom
No Relationships to Disclose
 
Nandakumar Packiriswamy
No Relationships to Disclose
 
Kah Whye Peng
Leadership - Imanis Life Sciences; Vyriad
Stock and Other Ownership Interests - Imanis Life Sciences; Vyriad
 
Alice Susannah Bexon
Employment - Bexon Clinical Consulting
Leadership - SapVax; Vyriad
Stock and Other Ownership Interests - Sapience Therapeutics; Vyriad
Travel, Accommodations, Expenses - Sapience Therapeutics; Vyriad